World's Best Scientists 2026 revealed!
Osamu Ogawa

Osamu Ogawa

D-Index & Metrics

Medicine

D-Index
90
Citations
29124
World Ranking
12223
National Ranking
360

Osamu Ogawa publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Osamu Ogawa sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 953 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Osamu Ogawa D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Osamu Ogawa sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Osamu Ogawa is affiliated with Kyoto University in Japan, with a primary research focus in Medicine. Their extensive work spans several subfields including Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology, and Urology.

The scientist's research extensively covers topics related to cancer treatment and diagnosis, particularly in the areas of prostate and bladder cancers. Key topics include:

  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Urinary and Genital Oncology Studies
  • Cancer Immunotherapy and Biomarkers
  • Urinary Bladder and Prostate Research
  • Renal cell carcinoma treatment

Frequent publication venues for Osamu Ogawa include journals that focus on urology, oncology, and cancer medicine. Notable venues and the number of publications in each are:

  • International Journal of Urology (14 publications)
  • The Journal of Urology (13 publications)
  • Cancer Medicine (7 publications)
  • Cancer Science (6 publications)
  • Journal of Clinical Oncology (4 publications)

The scientist has collaborated repeatedly with various coauthors, indicating a network of frequent partnerships. The most frequent coauthors and number of collaborations are:

  • Takashi Kobayashi (59 collaborations)
  • Shusuke Akamatsu (53 collaborations)
  • Takayuki Goto (38 collaborations)
  • Takahiro Inoue (29 collaborations)
  • Toshinari Yamasaki (26 collaborations)

Several recent publications illustrate the scope of Osamu Ogawa's research contributions across several high-impact journals and relevant medical fields. Recent papers include:

  • Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases, 2020, Nature Genetics
  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial, 2020, The Lancet Oncology
  • Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision, 2020, International Journal of Urology
  • Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys, 2020, Kidney International
  • Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab, 2020, Cancer Science

Best Publications

  • Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

    Osamu Ogawa;Michael R. Eccles;Jenny Szeto;Leslie A. McNoe

  • Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney

    Hideyuki Motohashi;Yuji Sakurai;Hideyuki Saito;Satohiro Masuda

  • Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

    Kazuyoshi Ishigaki;Kazuyoshi Ishigaki;Masato Akiyama;Masahiro Kanai;Masahiro Kanai;Atsushi Takahashi

  • Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters

    Yuko Tanihara;Satohiro Masuda;Tomoko Sato;Toshiya Katsura

  • Identification and Functional Characterization of a New Human Kidney–Specific H+/Organic Cation Antiporter, Kidney-Specific Multidrug and Toxin Extrusion 2

    Satohiro Masuda;Tomohiro Terada;Atsushi Yonezawa;Yuko Tanihara

  • Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6.

    Masao Doi;Yukari Takahashi;Rie Komatsu;Fumiyoshi Yamazaki

  • Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.

    Hiroya Oka;Yuji Chatani;Rika Hoshino;Osamu Ogawa

  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    Thomas Powles;Michiel S van der Heijden;Daniel Castellano;Matthew D Galsky

  • Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population

    Ryo Takata;Shusuke Akamatsu;Michiaki Kubo;Atsushi Takahashi

  • Cortical organization by the septin cytoskeleton is essential for structural and mechanical integrity of mammalian spermatozoa.

    Masafumi Ihara;Ayae Kinoshita;Shuichi Yamada;Hiromitsu Tanaka

  • Tumor Growth Inhibition by Arsenic Trioxide (As2O3) in the Orthotopic Metastasis Model of Androgen-independent Prostate Cancer

    Hiroshi Maeda;Seiji Hori;Hideki Nishitoh;Hidenori Ichijo

  • Collagenous matrices as release carriers of exogenous growth factors

    Akihiro Kanematsu;Shingo Yamamoto;Makoto Ozeki;Tetsuya Noguchi

  • Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.

    H Maeda;S Hori;H Ohizumi;T Segawa

  • Mosaic and polymorphic imprinting of the WT1 gene in humans.

    Yoshihiro Jinno;Kankatsu Yun;Kunihiko Nishiwaki;Kunihiko Nishiwaki;Takeo Kubota

  • Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma.

    Keisei Okamoto;Shinya Toyokuni;Koji Uchida;Osamu Ogawa

  • Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.

    Toru Yoshida;Hidefumi Kinoshita;Takehiko Segawa;Eijiro Nakamura

  • Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.

    Tomonori Habuchi;Takehiro Suzuki;Ryusei Sasaki;Lizhong Wang

  • Increased Risk of Prostate Cancer and Benign Prostatic Hyperplasia Associated with a CYP17 Gene Polymorphism with a Gene Dosage Effect

    Tomonori Habuchi;Zhang Liqing;Takehiro Suzuki;Ryusei Sasaki

  • Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer

    Hidefumi Kinoshita;Osamu Ogawa;Yoshiyuki Kakehi;Mutsuki Mishina

  • Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant.

    Yasushi Ichimura;Tomonori Habuchi;Norihiko Tsuchiya;Lizhong Wang

Frequent Co-Authors

Seiji Naito
Seiji Naito Kyushu University
Takashi Kobayashi
Takashi Kobayashi Oita University
Masahiro Hiraoka
Masahiro Hiraoka Kyoto University
Ken-ichi Inui
Ken-ichi Inui Kyoto Pharmaceutical University
Naoki Yoshimura
Naoki Yoshimura University of Pittsburgh
Masaaki Ito
Masaaki Ito Mie University
Hiroshi G. Okuno
Hiroshi G. Okuno Waseda University
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Fumihiko Matsuda
Fumihiko Matsuda Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, exploring related online degrees can open doors to diverse healthcare professions. Many students start with a nursing education. For those seeking accessible options, some schools offer programs in nursing school without teas test requirements, allowing you to begin your nursing journey without extra standardized testing.

A healthcare administration associate degree online is another excellent choice for those interested in the managerial and organizational side of healthcare. This degree equips you with the skills needed for leadership roles in hospitals, clinics, and insurance companies.

If you’re already a registered nurse, consider rn to np programs to advance your qualifications and transition into a nurse practitioner role. These bridge programs help experienced nurses move quickly toward advanced practice and greater responsibility.

For those driven by promoting healthy lifestyles, a bachelor's in nutrition online can lead to careers in dietetics, wellness coaching, or public health. These degrees offer flexibility for busy learners and help meet the growing demand for nutrition experts in healthcare settings.

Best Scientists Citing Osamu Ogawa

Trending Scientists

Recently Published Articles